<DOC>
	<DOC>NCT02248506</DOC>
	<brief_summary>To determine proportion of women achieving clinical and mycological cure or have recurrences / reinfection after being treated for an acute episode of vulvovaginal candidiasis.</brief_summary>
	<brief_title>Epidemiological Study About the Evolution of Patients Treated for an Acute Episode of Vulvovaginal Candidiasis</brief_title>
	<detailed_description />
	<mesh_term>Candidiasis</mesh_term>
	<mesh_term>Candidiasis, Vulvovaginal</mesh_term>
	<criteria>Sexually active women between 18 and 50 years Patients attending to the gynecologist with acute vulvovaginal candidiasis. Patients requiring standard treatment with clotrimazole 500 single dose and that the decision to prescribe this treatment is prior to inclusion in the study. Women who agree to participate in the study and has signed the informed consent sheet. Use of any medication that may interfere significantly with study assessments. Pregnant or breastfeeding Women with signs of other genital infection Within 3 months after childbirth or abortion Patients that is expected not to attend followup visits</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>March 2015</verification_date>
	<keyword>Candidiasis</keyword>
</DOC>